#TITLE_ALTERNATIVE#
Reteplase recombinant is a recombinant plasminogen activator (rPA) of alteplase<br /> derivatives used as thrombolytic for the treatment of acute myocardial infarction.<br /> Reteplase has been approved by FDA and EMA since 1996. However, reteplase has<br /> never been produced or...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/25339 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Reteplase recombinant is a recombinant plasminogen activator (rPA) of alteplase<br />
derivatives used as thrombolytic for the treatment of acute myocardial infarction.<br />
Reteplase has been approved by FDA and EMA since 1996. However, reteplase has<br />
never been produced or marketed in Indonesia until now and has an expensive price.<br />
Reteplase is produced in Escherichia coli and tends to form inclusion body because<br />
it has nine disulfide bonds. The objective of this study was to optimize the dissolved<br />
reteplase production process using pET24b expression vector in E. coli<br />
BL21(DE3), to examine the activity and purify it with Ni-NTA affinity<br />
chromatography. Synthetic DNA coding codon optimized reteplase was brought by<br />
plasmid pET24b and referred as pET24b_ret. The production of reteplase was<br />
performed in recombinant E. coli BL21(DE3) carrying the plasmid with and<br />
without a pGroElDnaK chaperone plasmid. The recombinant E. coli was confirmed<br />
by the validity of it’s carried plasmid through the restriction analysis and<br />
sequencing of DNA encoding reteplase, GroEl and DnaK. Optimization of<br />
overproduction condition of reteplase protein was done by modify the temperature<br />
(20, 25, 37 and 40°C), Luria Bertani media composition (LB and ¼LB) and<br />
expression of reteplase in E. coli BL21(DE3) with or without pGroElDnaK. The<br />
culture was induced by isopropylthio-β-D-galactoside with a final concentration of<br />
0.05 mM at OD600 of 0.7-0.8. The overproduced reteplase was characterized using<br />
SDS-PAGE and analyzed with ImageJ software. Reteplase activity was determined<br />
with a tPA human chromogenic activity assay. The soluble form of produced<br />
reteplase was 1.14 ± 0.01 mg/g of wet cells and provided an activity of 45.97 IU/mg<br />
crude reteplase using production conditions at 20°C in recombinant E. coli without<br />
chaperones in LB media. While the highest insoluble of reteplase was produced at<br />
37°C in recombinant E. coli without chaperones in LB media that resulting 19.6 ±<br />
1.6 mg protein/g wet cells. The insoluble form of reteplase was successfully<br />
dissolved by 8 M urea, 0.1 M DTT in 50 mM pH 8 buffer Tris-Cl, and giving<br />
activity of 1.53 IU/mg crude reteplase but did not bind to Ni-NTA column. It can<br />
be concluded that reteplase can be produced in the active form using a plasmid<br />
pET24b_ret expression in E. coli BL21(DE3).<br />
<br />
|
---|